Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Allergy, Asthma & Clinical Immunology

Fig. 3

From: Comparison of cytokine expression and disease severity between plasma cell-dominant and eosinophil-dominant patients in chronic rhinosinusitis with nasal polyps

Fig. 3

The correlation between the eosinophil-dominant (the percentage of Congo red-positive cells) or plasma cell-dominant (the percentage of CD138-positive cells) phenotype and the three clinically measurable disease severity scores (LMK-CT, TPS and SNOT-22) was analyzed by the Pearson R test. (a~c) Correlations between the percentages of Congo Red-positive cells and (a) LMK-CT, (b) TPS, and (c) SNOT-22 expressions. (d~f) Correlations between the percentages of CD138-positive cells and (d) LMK-CT, (e) TPS, and (f) SNOT-22 expressions. LMK-CT: Lund-Mackay computed tomography; TPS: total nasal endoscopic polyp score; SNOT-22: 22-item sinonasal outcome test; *p < 0.05 was considered to indicate a statistically significant difference

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us